China CAS:65928-58-7 Manufacturer

We are going to make every single effort for being excellent and excellent, and accelerate our ways for standing while in the rank of international top-grade and high-tech enterprises for CAS:65928-58-7, We welcome clients, enterprise associations and mates from all parts in the world to speak to us and search for cooperation for mutual positive aspects.
CAS:65928-58-7, We take measure at any expense to achieve essentially the most up-to-date equipment and approaches. The packing of nominated brand is our a further distinguishing feature. The products to assure years of trouble-free service has attracted a great deal customers. The solutions are obtainable in improved designs and richer assortment, they're created scientifically of purely raw supplies. It readily available in a variety of designs and specs for your selection. The most recent kinds are a great deal better than the preceding one particular and they are quite popular with lots of prospects.

Hot Products

  • Dutasteride

    Dutasteride

    Dutasteride has EP, USP, CP, IP, JP specification. CEP and FDA available.

    CAS:164656-23-9

  • Estriol

    Estriol

    Estriol has CP, EP, USP specifications. DMF under filing.

    CAS:50-27-1

  • Megestrol Acetate

    Megestrol Acetate

    Megestrol acetate has CP, EP and USP specifications. DMF under filing.

    CAS:595-33-5

  • Mono-acetyl Ganciclovir

    Mono-acetyl Ganciclovir

    Mono-acetyl Ganciclovir Specification: Min 97.0%

    CAS:88110-89-8

  • Mifepristone Tablets

    Mifepristone Tablets

    Mifepristone Tablets Specifications:10mg*1
    Indications:Emergency Contraceptive
  • 3-Oxo-4-androsten-17β-carboxylic acid

    3-Oxo-4-androsten-17β-carboxylic acid

    3-Oxo-4-androsten-17β-carboxylic acid is an intermediate of Dutasteride.

    CAS:302-97-6

Send Inquiry

X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept